Phase 1 study of JNJ-69086420, an actinium-225-labeled antibody targeting human kallikrein-2, for advanced prostate cancer. Background: Prostate cancer is the leading cause of new cancer diagnoses and ...

MANCHESTER: Unlike Sunday, it was a bright and sunny morning here at the Old Trafford Cricket Ground on Monday. The surface, which had been under cover due to rain, probably saw the sunlight for the ...